Clinical Trials Browser

Phase 2 × Terminated × telisotuzumab vedotin × Clear all

NCT05513703 2025-10-24

A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Phase 2 Terminated

9 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms